percutaneous microwave ablation
Recently Published Documents


TOTAL DOCUMENTS

326
(FIVE YEARS 124)

H-INDEX

26
(FIVE YEARS 4)

Author(s):  
Jing-E Zhu ◽  
Yun-Chao Chen ◽  
Song-Yuan Yu ◽  
Hui-Xiong Xu

Schwannoma is a benign tumor that originates from Schwann cells in the nerve sheathing of cranial, other peripheral, or autonomic nerves. Patients often present with painless mass as the chief complaint. The main symptoms of this tumor are related to its size and specific nerve origin. At present, the pretreatment diagnosis is mainly made by ultrasound, CT, MR, or biopsy, and the main treatment is surgical resection. We reported a new treatment method for cervical schwannoma in a 65-year-old woman with a history of non-small cell lung cancer (NSCLC). When the patient’s neck mass was initially found with hoarseness and severe cough, it was considered as cervical lymph node metastasis of lung cancer due to her medical history. And she was diagnosed with schwannoma by core-needle biopsy after chemotherapy failed and the tumor shrank after the radiotherapy with no improvement of the clinical symptoms. After considering the physical condition, the patients were treated in our department for minimal invasiveness treatment. The patient was definitively diagnosed with cervical vagus schwannoma and was treated with ultrasound-guided microwave ablation of schwannoma under general anesthesia with systematic evaluation and improved preoperative examination. Her condition was stable, and the symptoms of severe cough disappeared after anesthesia resuscitation and the ablation. The tumor continued to shrink after the operation with no recurrence of cough symptoms. Ultrasound-guided percutaneous microwave ablation (MWA) for cervical vagus schwannomas might be a minimally invasive, effective, and relatively safe alternative to conventional treatment for those patients with severe symptoms.


2021 ◽  
Vol 13 (12) ◽  
pp. 6827-6837
Author(s):  
Shanda H. Blackmon ◽  
Rosalie M. Sterner ◽  
Patrick W. Eiken ◽  
Thomas J. Vogl ◽  
Bradley B. Pua ◽  
...  

2021 ◽  
Vol 150 (4) ◽  
pp. A32-A32
Author(s):  
Elmira Ghahramani Z. ◽  
Peter D. Grimm ◽  
Bahar Saremi ◽  
Kyuran A. Choe ◽  
Seetharam Chadalavada ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 1618
Author(s):  
Evgenia Efthymiou ◽  
Argyris Siatelis ◽  
Christos Liakouras ◽  
Georgios Makris ◽  
Michael Chrisofos ◽  
...  

The aim of the present study was to evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous microwave ablation (MWA) of renal cell carcinoma (RCC) along with identifying prognostic factors affecting the progression survival rate. Institutional database retrospective research identified 69 patients with a biopsy proven solitary T1a (82.6%) or TIb (17.4%) RCC who have underwent percutaneous CT-guided MWA. Kaplan–Meier survival estimates for events were graphed and Cox regression analysis was conducted. Mean patient age was 70.4 ± 11.5 years. Mean size of the lesions was 3 ± 1.3 cm. Mean follow up time was 35.6 months (SD = 21.1). The mean progression free survival time from last ablation was 84.2 months. For T1a tumors, the cumulative progression free survival rate for 1, 6, 12 and 36 months were 100% (SE = 0%), 91.2% (SE = 3.7%), 91.2% (SE = 3.7%) and 87.5% (SE = 4.4%); the recurrence free survival rate for T1a RCC was 94.9%. For T1b tumors, the cumulative progression free survival rate for 1, 6, 12 and 36 months were 100% (SE = 0%), 63.6% (SE = 14.5%), 63.6% (SE = 14.5%) and 63.6% (SE = 14.5%). Grade 1 complications were recorded in 5 (7.2%) patients. Significantly greater hazard for progression was found in cases with a tumor size > 4 cm (HR = 9.09, p = 0.048). No statistically important difference regarding tumor progression was recorded between T1a tumors with a diameter ≤3 cm and >3 cm. In summary, the results of the present study show that CT guided percutaneous MWA is an effective technique for treatment of T1a renal cell carcinomas, irrespective of tumor size. T1b tumors were associated with higher progression rates.


2021 ◽  
Vol 206 (Supplement 3) ◽  
Author(s):  
Clinton Yeaman ◽  
Lauren O'Connor ◽  
Jennifer Lobo ◽  
Anthony DeNovio ◽  
Christopher Ballantyne ◽  
...  

Author(s):  
Clinton Yeaman ◽  
Lauren O'Connor ◽  
Jennifer Lobo ◽  
Anthony DeNovio ◽  
Rebecca Marchant ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Zhiguang Yao ◽  
Qingjing Zeng ◽  
Xuan Yu ◽  
Shulian Lin ◽  
Shuanglan Jiang ◽  
...  

Focal nodular hyperplasia (FNH) is a rare benign tumor-like space-occupying lesion of the liver that is especially rare in children. Since there have been no reports of malignant progression of this disease and these lesions remain unchanged for a long period of time or even disappear in some cases, it remains controversial whether clinical treatment is needed. However, if the diagnosis is unclear, the patient has symptoms or the lesion becomes enlarged during follow-up, clinical treatment should be considered. Here, we report the first case of FNH near the gallbladder treated by ultrasound-guided percutaneous microwave ablation (MWA) in a 9-year-old girl.


Sign in / Sign up

Export Citation Format

Share Document